Home›Legal›Ipamorelin in New York
Ipamorelin in New York: Legal Status & Provider Guide (2026)
Quick Answer
Ipamorelin is a prescription substance in the United States. Ipamorelin is an unapproved research peptide with no FDA bulk compounding authorization. While it has been offered by compounding pharmacies under various interpretations, federal compliance risk is elevated. Patients should verify current regulatory standing with their provider. In New York, compounding is governed by the New York State Board of Pharmacy (NYSBP). New York requires a collaborative practice agreement for nurse practitioners prescribing controlled substances, but NPs with full prescriptive authority may prescribe most compounded peptides independently. Physician assistants require physician supervision for prescribing. New York's telehealth prescribing rules require prescribers to hold a New York license; interstate telemedicine prescribing is tightly regulated.
Federal Legal Status
FDA Approval Status
Not FDA-approved as a drug. Not on the FDA 503A or 503B bulk substances lists. Ipamorelin's compounding status is contested — it was removed from the 503A consideration list and faces similar restrictions to other unapproved peptides.
Compounding Pharmacy Rules (Federal)
Ipamorelin is not on the FDA-approved 503A or 503B bulk substances lists. Some compounding pharmacies have offered it historically, but FDA guidance suggests significant legal risk. Its status is often treated similarly to CJC-1295 and other non-listed peptides. Legal compounding under federal oversight is uncertain.
Also Known As
NNC 26-0161
Primary Research Areas
- Growth hormone stimulation
- Anti-aging
- Body composition
- Recovery
New York Pharmacy Board & Compounding Rules
Compounding Overview
New York has among the most stringent pharmacy and prescribing regulations in the country. The New York State Board of Pharmacy enforces USP 797 and 795 standards and requires all compounding pharmacies to meet detailed quality and documentation requirements. New York has been particularly active in enforcing against unapproved compounded medications. In-state telehealth peptide providers are subject to strict New York Medical Board oversight.
Notable Rules
- New York requires compounding pharmacies to register separately for sterile compounding.
- The New York Department of Health has enforcement authority over unlicensed pharmaceutical activity.
- New York has stricter-than-federal requirements for documentation of medical necessity for compounded preparations.
- Interstate prescribing into New York requires a New York state license.
- New York and Pennsylvania maintain reciprocal pharmacy licensure recognition for some categories.
Prescribing Requirements in New York
New York requires a collaborative practice agreement for nurse practitioners prescribing controlled substances, but NPs with full prescriptive authority may prescribe most compounded peptides independently. Physician assistants require physician supervision for prescribing. New York's telehealth prescribing rules require prescribers to hold a New York license; interstate telemedicine prescribing is tightly regulated.
About Ipamorelin
Ipamorelin is a selective growth hormone secretagogue (GHSR agonist) and a pentapeptide. It stimulates growth hormone release with reportedly high selectivity — less stimulation of cortisol and prolactin than earlier GHRPs. Most evidence comes from animal studies.
For more research information, mechanism of action, and provider availability, see the Ipamorelin research profile on PeptideBase.
Frequently Asked Questions
- Is ipamorelin legally available from compounding pharmacies?
- Ipamorelin is not on the FDA bulk substances lists for 503A or 503B compounding. Some pharmacies have offered it, but federal compliance is uncertain. The regulatory environment has tightened since 2021. Patients should ask their provider for explicit documentation of the legal basis.
Ipamorelin Providers in New York
No providers currently listed in New York for Ipamorelin. Browse the full directory to find providers offering Ipamorelin.
Browse all Ipamorelin providers →Ipamorelin Legal Status in Other States
Pharmacy board rules and compounding regulations vary by state. Compare Ipamorelin legal status across other major markets:
Content review: This educational overview is prepared by the PeptideBase editorial team and reviewed for factual accuracy. Reviewer byline coming soon (gated on 4.4). Last updated: .